INHIBITION OF ALPHA-SYNUCLEIN TOXICITY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100273776A1
SERIAL NO

12294893

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds and compositions are provided for treatment or amelioration of one or more symptoms of α-synuclein toxicity, α-synuclein mediated diseases or diseases in which α-synuclein fibrils are a symptom or cause of the disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FOLDRX PHARMACEUTICALS INC100 ACORN PARK DRIVE 5TH FLOOR CAMBRIDGE MA 02140-2303

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bulawa, Christine Ellen Arlington, US 10 51
Fleming, James Somerville, US 35 345
Gupta, Sandeep Concord, US 156 2128
Labaudinière, Richard Sherborn, US 3 29
Liang, Feng Sudbury, US 376 3176
Lindquist, Susan L Chestnut Hill, US 34 256
Outeiro, Tiago Cambridge, US 9 80
Ripka, Amy Winthrop, US 50 606
Weigel, Charlotte Melrose, US 1 21

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation